GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis GLP-1 Agonists Help in Type 2 Diabetes With Liver Cirrhosis
In adults with cirrhosis and type 2 diabetes, glucagon-like peptide-1 receptor agonist therapy significantly lowered the risk for death and other adverse outcomes, a study found.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Cirrhosis | Diabetes | Diabetes Type 2 | Endocrinology | Gastroenterology | Health | Liver | Study | Urology & Nephrology